PHK
RMD icon

Point72 Hong Kong’s ResMed RMD Stock Holding History

Point72 Hong Kong’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,500
Closed -$849K – 2335
2022
Q1 		$849K Sell
3,500
-4,700
-57% -$1.14M 0.03% 567
2021
Q4 		$2.14M Buy
8,200
+3,700
+82% +$960K 0.07% 315
2021
Q3 		$1.19M Sell
4,500
-6,900
-61% -$1.89M 0.04% 678
2021
Q2 		$2.81M Buy
+11,400
New +$2.4M 0.09% 295
2021
Q1 		– Sell
-3,000
Closed -$638K – 2147
2020
Q4 		$638K Buy
+3,000
New +$598K 0.03% 633

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Point72 Hong Kong's RMD Position: Q3 2022 in Review

Point72 Hong Kong sold out of ResMed (RMD) in Q3 2022, closing a stake of 840 shares — an estimated $176K sold.

Point72 Hong Kong first reported a position in RMD in Q1 2016 and held it in 9 quarters. The position peaked at $676K in Q3 2020. 667 funds tracked by Wall St. Rank hold RMD as of Q3 2022.

  • Point72 Hong Kong reported no remaining ResMed position as of Q3 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 840 ResMed shares in Q3 2022, an estimated $176K.
  • Point72 Hong Kong first reported a position in ResMed in Q1 2016 and held it in 9 quarters.
  • Point72 Hong Kong's ResMed position peaked at $676K in Q3 2020.
  • 667 funds tracked by Wall St. Rank held ResMed as of Q3 2022.

Based on Point72 Hong Kong's 13F filing for Q3 2022, filed 14 Nov 2022.